ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OGI OrganiGram Holdings Inc

2.17
0.00 (0.00%)
05 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
OrganiGram Holdings Inc TSX:OGI Toronto Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.17 2.16 2.18 2.18 2.14 2.14 31,868 21:00:02

Organigram Announces the Issuance of RSU Awards

31/08/2018 7:18pm

PR Newswire (Canada)


OrganiGram (TSX:OGI)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more OrganiGram Charts.

MONCTON, NB, Aug. 31, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana, today announced the grant of restricted share units ("RSUs") to certain officers, directors and employees of the Company.

Pursuant to the terms of the Equity Incentive Plan (the "Plan") of the Company as approved by shareholders at the Annual and Special Meeting of the Shareholders held December 19, 2017, 145,201 RSUs were today awarded to officers, directors and employees pursuant to the Company's Plan. The RSUs shall vest in three equal tranches, on August 31, 2019, August 31, 2010 and August 31, 2011, unless otherwise varied pursuant to the terms of the Plan.

The issuance of the RSUs are subject to all required approvals, including, if applicable, the approval to the TSX Venture Exchange.

About Organigram Holdings Inc.

Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.

Organigram is focused on producing the highest-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company's global footprint. In anticipation of the legal adult use recreational cannabis in Canada, Organigram has developed a portfolio of brands including The Edison Cannabis Company, Ankr Organics and Trailer Park Buds. Organigram's primary facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations ("ACMPR"). 

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking information which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectations. Important factors - including the availability of funds, consummation of definitive documentation, the results of financing efforts, crop yields - that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE OrganiGram

Copyright 2018 Canada NewsWire

1 Year OrganiGram Chart

1 Year OrganiGram Chart

1 Month OrganiGram Chart

1 Month OrganiGram Chart

Your Recent History

Delayed Upgrade Clock